Skip to content

Thoracodorsal Artery Perforator Flap Versus Conventional Free Flaps

Thoracodorsal Artery Perforator Flap Versus Other Conventional Free Flaps in Soft Tissue Reconstruction

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03658603
Enrollment
40
Registered
2018-09-05
Start date
2018-10-03
Completion date
2021-02-28
Last updated
2018-09-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Trauma

Brief summary

The purpose of this study is to assess the efficacy of the thoracodorsal artery perforator flap versus other conventional free flaps for reconstruction of soft tissue defects.

Detailed description

The field of plastic surgery, unlike most other surgical specialties, has no anatomic or functional area to which it can lay claim; the plastic surgeon practices methods and techniques applicable to all specialties and anatomic areas. Reconstructive surgery is the process of restoring the human body to whole following tumor extirpation, infection, trauma or congenital or acquired deformity - restoring both form and function. The purpose of this study is to assess the efficacy of the thoracodorsal artery perforator flap versus other conventional free flaps for reconstruction of soft tissue defects.

Interventions

PROCEDUREthoracodorsal artery perforator flap

fascio-cutaneous flap used in cases of trauma or burns

musculo-cutaneous flap used in cases of trauma or burns

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
6 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

• Soft tissue loss anywhere in the body.

Exclusion criteria

• Patients with chronic debilitating diseases e.g. chronic renal failure, uncontrolled diabetes mellitus

Design outcomes

Primary

MeasureTime frameDescription
The mean operative time12 hoursthe time from the start to the end of operation

Secondary

MeasureTime frameDescription
The percentage of patients with Flap viability1 weekThe perforator flap will be assessed regarding (color, temperature, capillary refilling, congestion, blistering)

Contacts

Primary ContactMohamed Shazly, M.D
elshazly@aun.edu.eg01006667095
Backup ContactAhmed Tohamy, M.D
01002660832

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026